↓ Skip to main content

Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide

Overview of attention for article published in Investigational New Drugs, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus
2 Google+ users

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
32 Mendeley
Title
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
Published in
Investigational New Drugs, September 2013
DOI 10.1007/s10637-013-0028-7
Pubmed ID
Authors

Changhoon Yoo, Jeeyun Lee, Sun Young Rha, Kyong Hwa Park, Tae Min Kim, Yu Jung Kim, Hyo Jin Lee, Kyung Hee Lee, Jin-Hee Ahn

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
United States 1 3%
Unknown 30 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 16%
Student > Bachelor 5 16%
Student > Doctoral Student 3 9%
Researcher 3 9%
Student > Master 3 9%
Other 6 19%
Unknown 7 22%
Readers by discipline Count As %
Medicine and Dentistry 11 34%
Agricultural and Biological Sciences 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 9%
Unknown 10 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2018.
All research outputs
#13,750,494
of 23,312,088 outputs
Outputs from Investigational New Drugs
#695
of 1,188 outputs
Outputs of similar age
#104,732
of 198,959 outputs
Outputs of similar age from Investigational New Drugs
#17
of 27 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,188 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,959 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.